Loading...
Loading...
Prosensa Holding NV
RNA shares climbed 62.28% to $18.57 after BioMarin Pharmaceutical
BMRN announced its plans to acquire Prosensa for $17.75 per share.
Cimatron
CIMT shares jumped 43.46% to $8.72 after 3D Systems
DDD announced its plans to acquire Cimatron for $8.97 per share.
Platinum Underwriters Holdings
PTP shares gained 19.24% to $73.06 after the company agreed to be acquired by RenaissanceRe Holdings
RNR for $76 per share.
Tetraphase Pharmaceuticals
shares climbed 13.17% to $25.00 According to Bloomberg, Tetraphase Pharma is exploring a sale option after being approached by potential buyers, people familiar with the matter said.
Synthetic Biologics
SYN rose 7.88% to $1.58 after the company reported that it is safe-to-proceed under IND to initiate clinical trials of SYN-004 for the prevention C. difficile infection.
Regulus Therapeutics
Loading...
Loading...
surged 6.78% to $17.33. Deutsche Bank initiated coverage on Regulus Therapeutics with a Buy rating and a $30.00 price target.
Sarepta Therapeutics
SRPT shares rose 5.85% to $16.65 after BioMarin Pharmaceutical announced its plans to acquire Prosensa for $17.75 per share.
China Ming Yang Wind Power Group
MY rose 5.21% to $2.83 after the company reported Q3 earnings of $0.09 per share on revenue of $279.70 million.
Geron
GERN shares rose 4.86% to $3.88 after surging 13.85% on Friday.
Ariad Pharmaceuticals
ARIA gained 4.45% to $6.81 after the company announced the marketing approval of Iclusig (ponatinib) in Australia.
Loading...
Loading...
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in